Date |
Report No. |
Title |
Date Nov. 9, 2009 |
Report No. GAO-10-68 |
Title
United States Government Accountability Office GAO
November 2009 Report to the Ranking Member, Committee on Finance, U.S. Senate DRUG SAFETY FDA Has Begun Efforts to Enhance Postmarket Safety, but Additional Actions Are Needed GAO-10-68 November 2009 DRUG SAFETY Highlights
Highlights of GAO-10-68, a report to the Ranking Member, Committee on Finance, U.S. Senate Accountability Integrity Reliabilit... |
Date June 30, 2008 |
Report No. GAO-08-829R |
Title
United States Government Accountability Office Washington, DC 20548 June 30, 2008 The Honorable James L. Oberstar Chairman Committee on Transportation and Infrastructure House of Representatives The Honorable Peter A. DeFazio Chairman Subcommittee on Highways and Transit Committee on Transportation and Infrastructure House of Representative Subject: Examples of Job Hopping by Commercial Drivers af... |
Date May 15, 2008 |
Report No. GAO-08-600 |
Title
United States Government Accountability Office GAO
May 2008 Report to Congressional Requesters MOTOR CARRIER SAFETY Improvements to Drug Testing Programs Could Better Identify Illegal Drug Users and Keep Them off the Road GAO-08-600 May 2008 MOTOR CARRIER SAFETY Highlights
Highlights of GAO-08-600, a report to congressional requesters Accountability Integrity Reliability Improvements to Drug Testi... |
Date May 22, 2007 |
Report No. GAO-07-898T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Tuesday, May 22, 2007 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives PEDIATRIC DRUG RESEARCH The Study and Labeling of Drugs for Pediatric Use under the Best Pharmaceuticals for Children Act
Statement of Marcia Crosse Director, Health Care G... |
Date March 22, 2007 |
Report No. GAO-07-557 |
Title
United States Government Accountability Office GAO
March 2007 Report to Congressional Committees PEDIATRIC DRUG RESEARCH Studies Conducted under Best Pharmaceuticals for Children Act GAO-07-557 March 2007 PEDIATRIC DRUG RESEARCH Highlights
Highlights of GAO-07-557, a report to congressional committees Accountability Integrity Reliability Studies Conducted under Best Pharmaceuticals for Children Ac... |
Date Nov. 17, 2006 |
Report No. GAO-07-49 |
Title
United States Government Accountability Office GAO
November 2006 Report to Congressional Requesters NEW DRUG DEVELOPMENT Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts GAO-07-49 November 2006 NEW DRUG DEVELOPMENT Highlights
Highlights of GAO-07-49, a report to congressional requesters Accountability Integrity Reliability Science, Busines... |
Date May 17, 2005 |
Report No. GAO-05-653T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:30 a.m. EDT Tuesday, May 17, 2005 Testimony Before the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives DRUG TESTS Products to Defraud Drug Use Screening Tests Are Widely Available
Statement of Robert J. Cramer, Managing Director Office of Speci... |
Date Aug. 17, 2001 |
Report No. GAO-01-1051R |
Title
United States General Accounting Office Washington, DC 20548 August 17, 2001 The Honorable Eleanor Holmes Norton Ranking Minority Member Subcommittee on the District of Columbia Committee on Government Reform House of Representatives Subject: Criminal Justice Statistics for Washington, D.C., and Other Major Cities Dear Ms. Norton: On July 20, 2001, we testified at an oversight hearing—which focu... |
Date July 6, 2001 |
Report No. GAO-01-754 |
Title
United States General Accounting Office GAO
July 2001 Report to Congressional Requesters WOMEN’S HEALTH Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement GAO-01-754 Contents Letter
Results in Brief Background FDA’s Regulation Not As Specific As Earlier Guidance NDA and IND Submissions Often Fail to Present Required Information NDAs Include Appropriate Numb... |
Date June 30, 2000 |
Report No. HEHS-00-135R |
Title
United States General Accounting Office Washington, DC 20548 Health, Education, and Human Services Division B-285112 June 30, 2000 The Honorable John L. Mica Chairman, Subcommittee on Criminal Justice, Drug Policy, and Human Resources Committee on Government Reform House of Representatives Subject: Medicare: Contractors Screen Employees but Extent of Screening Varies Dear Mr. Chairman: In fiscal y... |
Date July 31, 1997 |
Report No. GGD-97-106 |
Title
United States General Accounting Office GAO
July 1997 Report to the Committee on the Judiciary, U.S. Senate, and the Committee on the Judiciary, House of Representatives DRUG COURTS Overview of Growth, Characteristics, and Results GAO/GGD-97-106 GAO United States General Accounting Office Washington, D.C. 20548 General Government Division B-275268 July 31, 1997 The Honorable Orrin G. Hatch Chairma... |
Date Feb. 11, 1993 |
Report No. GGD-93-61 |
Title
i I . -..-“-l_l... .--_I _.I_.... _1.-1---. _~.- ..-.---__. ^._..l,ll_* .-., I DRUG CONTROL Treatment Alternatives Program for Drug Offenders Needs Stronger Emphasis 148542 GAO United States General Accounting OfTIce Washington, D.C. 20848 General Government Division B-252082 February 11,1993 The Honorable Charles B. Range1 Chairman, Select Committee on Narcotics Abuse and Control House of Repre... |
Date Nov. 23, 1992 |
Report No. GGD-93-13 |
Title
NOWIII~WI l!W EMPLOYEE DRUG TESTING Opportunities Exist to Lower Drug-Testing Program Costs 148204 . RESTRICTED--Not to be released outside the General Accounting Office ui2less specifically approved by the Office of Congressional Relations:> s%629 RELEASED - .^ ._ _ ._., .._. . ._. ..-. ...- ...__ I *I- -_ . . . I . ...” I” . . .._ ..- ..__ _..... _.._ -.“.-_. “_ __“.“l II__ ._.------... |
Date Oct. 29, 1992 |
Report No. HRD-93-17 |
Title
IJnited States General Accounting Office Report to Congressional Requesters Octobt?r 1992 WOMEN’ HEALTH S FDA Needs to Ensure More Study of Gender Differences~ in Prescription Drug Testing, II II
147861 GAO/HRD-93-1’ 7 . United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-243898 October 29,1992 The Honorable Henry A. Waxman Chairman, Subcommittee on Health... |
Date June 10, 1992 |
Report No. GGD-92-99 |
Title
IJtrit,ctrf States Gent!ral Accounting Olfiw |
Date May 6, 1991 |
Report No. GGD-91-70 |
Title
EMPLOYEE DRUG Status of Federal Agencies’ Programs GAO General Accounting Office Washington, D.C. 20648 National Security and International Affairs Division united states
B-242712 May 6,199l The Honorable John Glenn Chairman, Committee on Governmental Affairs United States Senate Dear Mr. Chairman: This report, prepared in response to your request, discusses the status of federal agencies’ dru... |
Date Feb. 19, 1991 |
Report No. T-GGD-91-6 |
Title
. ’ .’ . United States General Accounting Office / 4 31 7 q GAO
For Release on Delivery 2:00 P.M. EST Tuesday February 19, 1991 Testimony EMPLOYEE DRUG TESTING A Single Manage Agency Federal Is Needed To Drug Testing Employee Statement of Bernard L. Ungar, Director Federal Human Resource Management General Government Division Before the Subcommittee on Treasury, and General Government Committe... |
Date Jan. 18, 1991 |
Report No. GGD-91-25 |
Title
GAO
-~-~.JiIllllary 1!)!)1 --- EMPLOYEE TESTING DRLJG A Single Agency Is Needed to Manage Federal Employee Drug Testing General Government Division B-240487 January 18,199l The Honorable Dennis DeConcini Chairman, Subcommittee on Treasury, Postal Service, and General Government Committee on Appropriations United States Senate The Honorable Barbara Mikulski United States Senate This report, prepare... |
Date April 6, 1990 |
Report No. GGD-90-56FS |
Title
-7 United Sta\es General Accounting Office Gil0
April 1990 Fact Sheet for the Chairman, Subcommittee on Treasury, Postal Service, and General Government, Committee on Appropriations, US. Senate DRUG TESTING Action by Certain Agencies When Employees Test Positive for Illegal Drugs
--, RlllHlllR RR
141330 ?a -~ GAO/GGD-90-66FS United States General Accounting Offke Washington, D.C. 20548 General Gov... |
Date Nov. 27, 1989 |
Report No. RCED-90-31 |
Title
I
United States General Accounting Office - GAO
November 1989 on Investigations and Oversight, Committee on Public Works and Transportation, House of Representatives Report to the Chairman, Subcommittee - DRUG TESTING Management Problems and Legal Challenges Facing DOT’s Industry Programs Resources, Community, Economic Development and Division B-234505
November 27, 1989 The Honorable Glenn M. An... |
Date Sept. 29, 1989 |
Report No. GGD-89-80 |
Title
RESTRICTED-- GAO United States General Accounting Office Washington, D.C. 20548 General Government Division B-235059 September 29,1989 The Honorable Dennis DeConcini Chairman, Subcommittee on Treasury, Postal Service, and General Government Committee on Appropriations United States Senate Dear Mr. Chairman: On August 2,1989, we briefed your representative as part of our ongoing review of agency dr... |
Date May 30, 1989 |
Report No. GGD-89-75 |
Title
Not to be released outside RESTRICTED-General Accounting Office unless specifically approved by the Office of Congressional Relations. nrr morn the United States General Accounting Office Washington, D.C. 20548 General Government Division B-223280 May 30,1989 The Honorable Gerry Sikorski Chairman, Subcommittee on Civil Service Committee on Post Office and Civil Service House of Representatives The... |
Date March 1, 1989 |
Report No. GGD-89-51 |
Title
, : .’ ^ GAO United States General Accounting Office Washington, D.C. 20648 General Government Division B-223280 March I,1989 The Honorable Dennis DeConcini Chairman, Subcommittee on Treasury, Postal Service, and General Government Committee on Appropriations United States Senate Dear Mr. Chairman: Senate Report loo-387 on the fiscal year 1989 Treasury, Postal Service, and General Government App... |
Date Sept. 2, 1988 |
Report No. GGD-88-127FS |
Title
United States General Accounting Office GAO
September 1988 Fact Sheet for the Honorable Charles E. Schumer, House of Representatives EMPLOYEE DRUG TESTING Regulation of Drug Testing Laboratories !W3TRICTED--Not to be released outside the General Accounting Offke except on the basis of the specific approval by the Office of CongressionalRelations. GAO United States General Accounting Offke Washingt... |
Date June 16, 1988 |
Report No. T-GGD-88-40 |
Title
United States General Accounting OfBee / GAO Testimony For Release on Delivery Expected at 9:30 a.m. EDT Thursday June 16, 1988 FEDERAL EMPLOYEE DRUG TESTING Statement of Associate L. Nye Stevens, General Government Division Before the Subcommittee Director on Human Resources and on Civil Service Subcommittee Committee on Post Office and Civil United States House of Representatives Service 136078 ... |
Date April 21, 1988 |
Report No. T-GGD-88-14 |
Title
UnitedStatesGeneralAccountingOffke Testimony For Release on Delivery Expected at 1O:OO a.m. EDT Thursday April 21, 1988 Employee Drug Testing Statement of Associate L. Fye Stevens, General Government Division Before the Subcommittee on Employment Committee on Education and Bouse of Representatives Director Opportunities Labor @b\qLtip
GAO\T-GGD-88-14 I i-35 (c3C EMPLOYEE DRUG TESTING SUMMARY OF ST... |
Date March 2, 1988 |
Report No. GGD-88-32 |
Title
- Charles Schumer, House of, Representatives .
March1988 EMPLOYEEDRUG TESTING+: InformationonPrivak sector Programs RESTRICTED-Not to be re!easedoutside the Qneraf Accounting Of&e except on the basis of the specific approval by the Oflice of CongressionalRelations. 3AO/GGD-88-32 suc\L)38 GAO United States General Accounting Office Washington, D.C. 20548 General Government Division B-223280 March 2... |
Date May 20, 1987 |
Report No. T-GGD-87-18 |
Title
Unbd Stat& Gws~ral Accounting Of!fice 1% Testimony For Release on Delivery Expected at 9:30 a.m. EDT Wednesday May 20, 1987 FEDERAL EMPLOYEEDRUG TESTING . Statement of L. Nye Stevens, Associate Director General Government Division Before the Subcommittee on Human Resources Committee on Post Office and Civil Service United States House of Representatives 133001 03Y4~0
bAO/T-GGD-87-18 Mr. Chairman t... |
Date May 1, 1987 |
Report No. 133014 |
Title
3 Annual Report FOREWORD This the period three makeup addressed undertaken addition, the the through body The intensive
1984 GS-13/14 report summarizes and through
(1) the Policy activities Advisory The 1986. section a section for Council, on the and accomplishments of into and Management January sections: of the in by the December a background (2) to is the on the Council for the report is divide... |
Date Sept. 25, 1986 |
Report No. 131081 |
Title
UNITED STATES GENERAL ACCOUNTING OFFICE Washington, D.C. 20548 FOR RELEASE ON DELIV3RY EXPECTED AT lo:30 A.M. SEPTEMBER 25, 1986 STATEMENT OF WILLIAM ASSISTANT J. ANDERSON COMPTROLLER GENERAL FOR GENERAL GOVERNMENT PROGRAMS AND HARRY R. VAN CLEVE GENERAL COUNSEL BEFORE THE STJBCOMMITTEE ON HUMAN RESOURCES COMMITTEE ON POST OFFICE AND CIVIL SERVICE HOUSE OF REPRESENTATIVES Mr. pleasure Executive em... |
Date July 15, 1976 |
Report No. HRD-76-96 |
Title
Food and Drug /M-ministration Department of Health, Education, and Welfare The Food and Drug Administration has neither adequately monitored new drug tests nor adequately enforced compliance with testing requirements. Consequently, it lacks assurance (1) that the thousands of human subjects used in such tests annually are protected from unnecessary hazards of new drugs or (2) that the test data us... |